These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36708355)

  • 21. Diversity of short linear interaction motifs in SARS-CoV-2 nucleocapsid protein.
    Schuck P; Zhao H
    mBio; 2023 Dec; 14(6):e0238823. PubMed ID: 38018991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
    Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
    Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
    Iserman C; Roden CA; Boerneke MA; Sealfon RSG; McLaughlin GA; Jungreis I; Fritch EJ; Hou YJ; Ekena J; Weidmann CA; Theesfeld CL; Kellis M; Troyanskaya OG; Baric RS; Sheahan TP; Weeks KM; Gladfelter AS
    Mol Cell; 2020 Dec; 80(6):1078-1091.e6. PubMed ID: 33290746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The disordered N-terminal tail of SARS-CoV-2 Nucleocapsid protein forms a dynamic complex with RNA.
    Cubuk J; Alston JJ; Incicco JJ; Holehouse AS; Hall KB; Stuchell-Brereton MD; Soranno A
    Nucleic Acids Res; 2024 Mar; 52(5):2609-2624. PubMed ID: 38153183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.
    Rhamadianti AF; Abe T; Tanaka T; Ono C; Katayama H; Makino Y; Deng L; Matsui C; Moriishi K; Shima F; Matsuura Y; Shoji I
    J Virol; 2024 Sep; 98(9):e0085524. PubMed ID: 39120134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AlphaFold2 Reveals Structural Patterns of Seasonal Haplotype Diversification in SARS-CoV-2 Nucleocapsid Protein Variants.
    Ali MA; Caetano-Anollés G
    Viruses; 2024 Aug; 16(9):. PubMed ID: 39339835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results.
    Lesbon JCC; Poleti MD; de Mattos Oliveira EC; Patané JSL; Clemente LG; Viala VL; Ribeiro G; Giovanetti M; de Alcantara LCJ; Teixeira O; Nonato MC; de Lima LPO; Martins AJ; Dos Santos Barros CR; Marqueze EC; de Souza Todão Bernardino J; Moretti DB; Brassaloti RA; de Lello Rocha Campos Cassano R; Mariani PDSC; Slavov SN; Dos Santos RB; Rodrigues ES; Santos EV; Borges JS; de La Roque DGL; Kitajima JP; Santos B; Assato PA; da Silva da Costa FA; Banho CA; Sacchetto L; Moraes MM; Palmieri M; da Silva FEV; Grotto RMT; Souza-Neto JA; Nogueira ML; Coutinho LL; Calado RT; Neto RM; Covas DT; Kashima S; Elias MC; Sampaio SC; Fukumasu H
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA.
    Jack A; Ferro LS; Trnka MJ; Wehri E; Nadgir A; Nguyenla X; Fox D; Costa K; Stanley S; Schaletzky J; Yildiz A
    PLoS Biol; 2021 Oct; 19(10):e3001425. PubMed ID: 34634033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RG203KR Mutations in SARS-CoV-2 Nucleocapsid: Assessing the Impact Using a Virus-Like Particle Model System.
    Raheja H; Das S; Banerjee A; P D; C D; Mukhopadhyay D; Ramachandra SG; Das S
    Microbiol Spectr; 2022 Aug; 10(4):e0078122. PubMed ID: 35862952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
    Khan MT; Zeb MT; Ahsan H; Ahmed A; Ali A; Akhtar K; Malik SI; Cui Z; Ali S; Khan AS; Ahmad M; Wei DQ; Irfan M
    Arch Microbiol; 2021 Jan; 203(1):59-66. PubMed ID: 32749662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of SARS-CoV-2 Orf9b Regulates Its Targeting to Two Binding Sites in TOM70 and Recruitment of Hsp90.
    Brandherm L; Kobaš AM; Klöhn M; Brüggemann Y; Pfaender S; Rassow J; Kreimendahl S
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of SARS-CoV-2 nucleocapsid protein.
    Huang Y; Chen J; Chen S; Huang C; Li B; Li J; Jin Z; Zhang Q; Pan P; Du W; Liu L; Liu Z
    Front Cell Infect Microbiol; 2024; 14():1415885. PubMed ID: 38846351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 structural coverage map reveals viral protein assembly, mimicry, and hijacking mechanisms.
    O'Donoghue SI; Schafferhans A; Sikta N; Stolte C; Kaur S; Ho BK; Anderson S; Procter JB; Dallago C; Bordin N; Adcock M; Rost B
    Mol Syst Biol; 2021 Sep; 17(9):e10079. PubMed ID: 34519429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of a silent mutation in RNA binding domain of N protein coding gene from SARS-CoV-2.
    Zolfaghari Emameh R; Eftekhari M; Nosrati H; Heshmatnia J; Falak R
    BMC Res Notes; 2021 Jan; 14(1):10. PubMed ID: 33407800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5.
    Hatakeyama D; Masuda T; Miki R; Ohtsuki S; Kuzuhara T
    Biochem Biophys Res Commun; 2021 Jun; 557():273-279. PubMed ID: 33894414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conformational Flexibility and Local Frustration in the Functional States of the SARS-CoV-2 Spike B.1.1.7 and B.1.351 Variants: Mutation-Induced Allosteric Modulation Mechanism of Functional Dynamics and Protein Stability.
    Verkhivker G
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.
    Barona-Gómez F; Delaye L; Díaz-Valenzuela E; Plisson F; Cruz-Pérez A; Díaz-Sánchez M; García-Sepúlveda CA; Sanchez-Flores A; Pérez-Abreu R; Valencia-Valdespino FJ; Vega-Magaña N; Muñoz-Valle JF; García-González OP; Bernal-Silva S; Comas-García A; Cibrián-Jaramillo A
    Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The highly flexible disordered regions of the SARS-CoV-2 nucleocapsid N protein within the 1-248 residue construct: sequence-specific resonance assignments through NMR.
    Schiavina M; Pontoriero L; Uversky VN; Felli IC; Pierattelli R
    Biomol NMR Assign; 2021 Apr; 15(1):219-227. PubMed ID: 33660218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.